Back

bcrabk | 20762

BCR-ABL p210, p190, p230 initial diagnosis (bone marrow)

Keywords

Essential thrombocythemia Myeloproliferative Syndrome Myeloproliferative neoplasia, MPN

Material
Bone marrow blood
EDTA-Tube bone marrow (6)
Note

To be determined within 24h from sampling. | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order.
Stability 2 days / 18-25°C; 2 days / 2-8°C
Duration 5 days
Frequency 2 x per week
Method Next Generation Sequencing
Price CHF 954.90
Tariff 954.90 TP
Designation see single analyses

Single analyses

BCR-ABL p190 (Knochenmark)
bcr9dk Knochenmarkaspirat
bcr9dk Knochenmarkaspirat
BCR-ABL p230 (Knochenmark)
bcr3dk Knochenmarkaspirat
bcr3dk Knochenmarkaspirat
BCR-ABL p210 (Knochenmark)
bcr1dk Knochenmarkaspirat
bcr1dk Knochenmarkaspirat

Team of consultants

PD, MD Giuseppe Colucci FMH internal medicine, hematology, FAMH Specialist in laboratory medicine
FMH internal medicine, hematology, FAMH Specialist in laboratory medicine T +41 61 486 14 57
PhD Christian Kalberer FAMH Specialist in laboratory medicine, main field hematology
FAMH Specialist in laboratory medicine, main field hematology T +41 61 486 15 14
MD FMH hematology, FAMH Specialist in laboratory medicine Maurice Redondo Head of Routine laboratories
Head of Routine laboratories T +41 61 486 11 11